AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04578574 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Transcranial Direct Electrical Stimulation (tDCS)
Description: Each session of the Sham tDCS will be applied for 30 min at the same time as the BI.
Study NCT06450431 — intervention group
Intervention type: OTHER
Intervention: SF-36 questionnaire French version and PAS.fr questionnaire
Description: Patients will receive both the SF-36 questionnaire (control generic questionnaire for QoL evaluation validated in French language) and the PAS.fr questionnaire at the designated time (before surgery, 6, 12 or 36 months after surgery) during the consultation, or by mail. For concurrent validation of the PAS.fr questionnaire, a second questionnaire will be sent to the patients 2-4 weeks thereafter.
Study NCT06412328 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Psychoeducation
Description: The psychoeducation program based on psychosocial support is a total of 8 sessions. Families participating in the study received the psychoeducation program over 4 weeks, with two sessions per week, each session lasting 60 minutes. Parents were included in group work during the psychoeducation program.
Study NCT05158556 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myofascial Release Technique
Description: Myofascial Release Technique will be applied with forearm/ ulnar border of palm. Deep pressure will be applied and glided medially towards the thoraco-lumbar region.
Study NCT05158556 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instrument Assisted Soft tissue Mobilization
Description: instrument assisted soft tissue mobilization is done via M2T Blade. it is a multifunctional instrument consisting of many planes and is very effective in treating pain and spasm. Its efficacy is proven over soft tissues that it releases fascial tightness.
Study NCT05312788 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Effect of Barley Supplemented Wheat Bread on markers of Cardiovascular and Renal Health
Description: Intervention will involve intake of 50% barley substituted wheat bread.
Study NCT05312788 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Effect of Barley Supplemented Wheat Bread on markers of Cardiovascular and Renal Health
Description: Intervention will involve intake of 50% barley substituted wheat bread.
Study NCT05355233 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: bebo concept
Description: techniques to remove urinary incontinence
Study NCT05355233 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: diaphragmatic breathing
Description: techniques to remove urinary incontinence
Study NCT05141214 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Virtual Reality Application
Description: In VR application, Chaos Café, patients are immersed into a computer-generated kitchen environment. A humorous robotic chef serves children different food groups. Gameplay is advanced by choosing healthy foods, while eating unhealthy foods does not advance the application.
Study NCT05252156 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eXciteOSA
Description: eXciteOSA
Study NCT04923841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity light box for bright light therapy and single vision spectacle lenses
Description: High intensity light box for bright light therapy and single vision spectacle lenses
Study NCT04923841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity light box for bright light therapy and Defocus Incorporated Multiple Segments (DIMS) spectacle lenses
Description: High intensity light box for bright light therapy and Defocus Incorporated Multiple Segments (DIMS) spectacle lenses
Study NCT04923841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity light box for bright light therapy and atropine 0.01% eye drop and and single vision spectacle lenses
Description: High intensity light box for bright light therapy and atropine 0.01% eye drop and and single vision spectacle lenses
Study NCT04923841 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Atropine 0.01% eye drop and and single vision spectacle lenses
Description: Atropine 0.01% eye drop and and single vision spectacle lenses
Study NCT05073237 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Daily placebo tablet
Study NCT05073237 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: conjugated estrogens/bazedoxifene (CE/BZA)
Description: Participants assigned to CE/BZA will receive a daily tablet containing conjugated estrogens 0.45 mg and bazedoxifene 20mg.
Study NCT04911556 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum
Description: types of intestinal flora
Study NCT04911556 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: A placebo made of starch
Description: placebo
Study NCT04771611 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fisetin
Description: \~20mg/kg /day oral for four days (days 0,1 and days 8,9)
Study NCT04771611 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Looks exactly like the study drug, but it contains no active ingredient . Oral for four days (days 0,1 and days 8,9)
Study NCT05567783 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VIR-2482 (450 mg)
Description: VIR-2482 450mg given by intramuscular injection
Study NCT05567783 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VIR-2482 (1200 mg)
Description: VIR-2482 1200 mg given by intramuscular injection
Study NCT05567783 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Sterile 0.9% (w/v) sodium chloride solution given by intramuscular injection
Study NCT05670301 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: cytokine and lipidomic profiling
Description: * FEBRIS Cytokine Profile Assay (quantification of inflammatory cytokines)~* Serum amyloid A~* Biobanking of leftover sample for future analyses and specific immunofunctional assay in selected cases~* Lipidomics
Study NCT05827211 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Antibiotic group
Description: Partially or fully edentulous smoker patients will be treated by dental implants and will receive systemic antibiotics
Study NCT05827211 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Non-Antibiotic group
Description: Partially or fully edentulous smoker patients will be treated by dental implants and will receive placebo
Study NCT05519397 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Immune checkpoint measurement
Description: Measurement of sCD25 (IL-2Ra), 4-1BB, B7.2 (CD86), Free Active TGF-β1, CTLA-4, PD-L1, PD-1, Tim-3, LAG-3, Galectin-9
Study NCT06494917 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: pelvic floor exercises
Description: First arm; Pelvic Floor Exercises (PFE) consisting of diaphragm breathing training, bridge exercise to strengthen the pelvic floor, 3-dimensional diaphragm exercise, 'I Love you massage' for intestinal motility, happy baby pose, child position exercise, full squat, adductor and iliopsoas stretching, mermaid position exercise, 'Shhh' sound exercise, 'Üüüü' sound exercise will be applied.
Study NCT06494917 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pelvic floor exercises and manual therapy techniques
Description: Second arm; Pelvic Floor Exercises (PFE) consisting of diaphragm breathing training, bridge exercise to strengthen the pelvic floor, 3-dimensional diaphragm exercise, 'I Love you massage' for intestinal motility, happy baby pose, child position exercise, full squat, adductor and iliopsoas stretching, mermaid position exercise, 'Shhh' sound exercise, 'Üüüü' sound exercise will be applied. In addition to diaphragmatic breathing training and pelvic floor exercises, manual therapy methods such as momentum minus mobilisation, sphincter opening, colon massage, global fascia manipulation, trigger point and myofascial release will be applied.
Study NCT05128721 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Covi Vax
Description: Inactivated SARS-COV-2 Vaccine/alum adjuvant preparation in addition to excipients (NRC-VACC- 101) administered as an IM Injection. NRC-VACC-101 is provided as a single dose of inactivated vaccine of opaque white liquid free from visible particles filled in injection vial (2R) glass vials. Each Dose of Covi Vax Vaccine contains 6 mcg antigen of A human coronavirus (hCoV)-19/Egypt/NRC-03/2020 SARS-CoV-2 strain.
Study NCT05128721 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Covi Vax
Description: Inactivated SARS-COV-2 Vaccine/alum adjuvant preparation in addition to excipients (NRC-VACC- 101) administered as an IM Injection. NRC-VACC-101 is provided as a single dose of inactivated vaccine of opaque white liquid free from visible particles filled in injection vial (2R) glass vials. Each Dose of Covi Vax Vaccine contains 6 mcg antigen of A human coronavirus (hCoV)-19/Egypt/NRC-03/2020 SARS-CoV-2 strain.
Study NCT05090553 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lumbar Spinal Fusion Surgery
Description: During surgery will be collected five disc fragments and five fragments of muscle-ligament tissue adjacent to the collected disc.
Study NCT05090553 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bacterial culture
Description: Samples will be seeded on blood agar and anaerobic blood agar plates. After sowing in solid media, the swab will be inoculated in thioglycolate medium, where it will remain for 14 days
Study NCT05090553 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Phenotypic and genotypic characterization
Description: The phenotypic identification of the species will be carried out through mass spectrometry, with the MALDI-TOF equipment.~PCR analyzes performed in two phases, the first to confirm the presence of bacteria (target and non-target) using primers capable of amplifying eubacteria ribosomal deoxyribonucleic acid (rDNA) 16s and the second directed to confirm C. acnes through specific rDNA 16s primers.
Study NCT05090553 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Multiomics analysis
Description: Whole Genome Sequencing, proteomics and metabolomics analysis
Study NCT05928130 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: plyometric training protocol
Description: The plyometric training program will last for 4 weeks, with three sessions per week. The plyometric exercises will be performed immediately after a warm-up. The program will incorporate bilateral, unilateral, acyclic, cyclic, horizontal, vertical, lateral, and diagonal movements involving both slow and fast movements.~Each session will include 4-5 plyometric exercises, with 2-10 sets per exercise and 1-10 repetitions per set. The training volume will progressively increase from the 1st to the 2nd week and then the intensity will increase while the volume decreases from the 3rd to the 4th week in both intervention groups. However, the final volume will vary by 50% between the groups.
Study NCT05029960 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Brivaracetam
Description: Dose of 50 mg twice daily for 6 months
Study NCT05286697 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: measuring optic nerve diameter
Description: During the measurement of the optic nerve diameter, a layer of sterile water-soluble gel will be applied on the closed eyelid with a linear 10-5 MHz ultrasound probe.
Study NCT06528639 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HIIT
Description: Three times a week, 10 sets each session, for 24 weeks of high-intensity interval training.
Study NCT04768257 — intervention group
Intervention type: BEHAVIORAL
Intervention: Physical activity
Description: We will assess physical activity patterns of patients at baseline (at discharge from hospital or at patients' home), at 12 weeks and 6 months, through an objective measurement (triaxial accelerometer).
Study NCT06441084 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: NCR300 injection
Description: Subjects will receive at least 1 cycle of NCR300 injection.
Study NCT03920709 — intervention group
Intervention type: OTHER
Intervention: Blood sample and Nasal swabs (right an left) samples
Description: Nasal swabs (right and left) will be performed (FLOQSwabTM)~Blood samples of 20 mL EDTA will be taken in addition to the current care report
Study NCT04777253 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Biofeedback method
Description: Patients in the study group will participate in training with visual biofeedback, aimed to improve motor function of the arm. The exercise will be performed using a Biometrics device. The biofeedback training will be carried out for 30 minutes per day.~Health-resort based rehabilitation The patients will participate in a three-week rehabilitation program (from Monday to Friday), with the treatments and therapies continued for up to two hours per day.~The program will include: group and individual exercise (active and assisted exercises, manipulation exercise, PNF-based practice, balance and breathing exercise), manual massage, physical treatments, such as: laser, whirlpool therapy, mud compress therapy, carbonic acid therapy, TENS therapy, BIO-V lamp, and localized cryotherapy.
Study NCT04777253 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health-resort based rehabilitation
Description: The patients will participate in a three-week rehabilitation program (from Monday to Friday), with the treatments and therapies continued for up to two hours per day.~The program will include: group and individual exercise (active and assisted exercises, manipulation exercise, PNF-based practice, balance and breathing exercise), manual massage, physical treatments, such as: laser, whirlpool therapy, mud compress therapy, carbonic acid therapy, TENS therapy, BIO-V lamp, and localized cryotherapy
Study NCT04777253 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Health-resort based rehabilitation
Description: The patients will participate in a three-week rehabilitation program (from Monday to Friday), with the treatments and therapies continued for up to two hours per day.~The program will include: group and individual exercise (active and assisted exercises, manipulation exercise, PNF-based practice, balance and breathing exercise), manual massage, physical treatments, such as: laser, whirlpool therapy, mud compress therapy, carbonic acid therapy, TENS therapy, BIO-V lamp, and localized cryotherapy
Study NCT05620251 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Blood test
Description: Assessment of humoral immune response
Study NCT04709822 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Visuospatial Interference
Description: Two remote intervention sessions with a researcher including a simple cognitive task (a memory cue and 25 minutes of Tetris game play with mental rotation) alongside accompanying information.~Participants are instructed that they may continue using the technique self-guided after the first intervention session, and they may opt for additional intervention sessions with remote researcher support (maximum 6 intervention sessions).
Study NCT05518864 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IALURIL Prefill
Description: GAG therapy (bladder instillations with glycosaminoglycans)
Study NCT05015946 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Small-sided team handball training
Description: 60 minutes small-sided team handball training. Initial 20 minutes of warm-up including exercises for strength, aerobic, balance, coordination, and mobility. Hereafter 20 minutes of handball specific exercises including dribbling, running and shooting. Final 20 minutes of small-sided handball matches.
Study NCT06287723 — intervention group
Intervention type: BIOLOGICAL
Intervention: Blood sample/Liquid biopsy
Description: ctDNA analysis
Study NCT06109571 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Connections App
Description: The Connections app was developed for patients with substance use disorders or unhealthy substance use and adapted to include HIV support. For this study, it has been modified to provide additional resources to support patients engaged in HIV care. Connections' core features include agency-specific informational resources compiled in a resource center, patient self-monitoring through weekly check-in surveys, discussion rooms, and private messaging.
Study NCT06224608 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC)
Description: 1.0ml/bottle, containing 2.5μg/ml low dose, 5μg/ml medium dose, and 10μg/ml high dose of active ingredient.~Take 0.1ml and inject it into the center of the front 1/3 of the palm side of the forearm by the Montessori method Single dose administration.
Study NCT06421896 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: motivational Enhancement Therapy
Description: Motivational Enhancement Therapy (MET) is a systematic intervention that focuses on eliciting and strengthening a person's intrinsic motivation to change. MET is rooted in motivational interviewing principles, emphasizing empathy, autonomy, and the evocation of the patient's own motivations for change. The therapy typically involves several sessions where therapists help patients identify personal goals, explore ambivalence towards change, and develop actionable plans to achieve their desired outcomes.
Study NCT05887817 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Finerenone
Description: Study participants will be instructed to take either finerenone or placebo orally once daily (preferably at approximately the same time every during the morning). For study participants with baseline eGFR less than 60mL/min/1.73 m2, the starting dose will be 10mg/day of finerenone (equivalent to 10mg/day in the placebo group), followed by 20 mg/day (equivalent to 20mg/day in the placebo group) approximately 4 weeks after the first dose, in accordance with the latest package insert. The dose should be increased to 20mg/day (equivalent to 20mg/day in the placebo group) in principle after 4 weeks from the start of the first dose, in accordance with the latest package insert. Study participants with a baseline eGFR of 60 mL/min/1.73m2 or higher will receive 20mg/day of finerenone (equivalent to 20mg/day in the placebo group) as the starting dose.
Study NCT05887817 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Study participants will be instructed to take either finerenone or placebo orally once daily (preferably at approximately the same time every during the morning). For study participants with baseline eGFR less than 60mL/min/1.73 m2, the starting dose will be 10mg/day of finerenone (equivalent to 10mg/day in the placebo group), followed by 20 mg/day (equivalent to 20mg/day in the placebo group) approximately 4 weeks after the first dose, in accordance with the latest package insert. The dose should be increased to 20mg/day (equivalent to 20mg/day in the placebo group) in principle after 4 weeks from the start of the first dose, in accordance with the latest package insert. Study participants with a baseline eGFR of 60 mL/min/1.73m2 or higher will receive 20mg/day of finerenone (equivalent to 20mg/day in the placebo group) as the starting dose.
Study NCT05521802 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: B-cell maturation antigen (BCMA) directed chimeric antigen receptor (CAR)-T cell
Description: Autologous 2nd generation BCMA-directed CAR-T cells, single infusion intravenously
Study NCT06317896 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: circulating tumor cells
Description: blood sample and tissue specimen for circulating tumor cell and DNA will be done to patient with hepatocellular carcinoma
Study NCT05343026 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hearing aids
Description: As for screening the hearing and tinnitus testing, the measure typically comprises PTA, SRS, DPOAE, and several widely accepted standardized tinnitus questionnaires, including the THI for tinnitus severity and VAS for tinnitus loudness.
Study NCT04974515 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: eXciteOSA
Description: eXciteOSA is a device for improving genioglossus endurance through electrical stimulation
Study NCT04974515 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: eXciteOSA
Description: eXciteOSA is a device for improving genioglossus endurance through electrical stimulation
Study NCT05285488 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: focused attention group
Description: focused attention group: adult subjects practicing focused attention meditation.~contemplation group: adult subjects practicing contemplation meditation.
Study NCT05285488 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: focused attention group
Description: focused attention group: adult subjects practicing focused attention meditation.~contemplation group: adult subjects practicing contemplation meditation.
Study NCT05882253 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Restricted Spectrum Imaging-Magnetic Resonance Imaging (RSI-MRI)
Description: An advanced imaging software that supports improved prostate cancer detection and diagnosis
Study NCT05042037 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: (Microbial cell preparation) probiotics
Description: Lactobacillus acidophilus (107mg), Lactobacillus casei subsp (107mg), Lactobacillus lactis (107mg), Bifidobacterium bifidum (107mg), Bifidobacterium infantis (107mg) and Bifidobacterium longum (107mg)
Study NCT05042037 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo sachet with no microbial cell preparation
Study NCT06288321 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Microdrop Mydrin-P
Description: Microdrop Mydrin-P consists of around one third of the standard Mydrin-P drop size. Drop volume measurement was performed using a precision weight scale (Sartorius) with accuracy up to 0.001g. The microdrop administration was conducted via attachment of a 16 gauge needle to a 1ml syringe.